BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15229389)

  • 1. Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting.
    Hashiguchi M; Ohno K; Nakazawa R; Kishino S; Mochizuki M; Shiga T
    Cardiovasc Drugs Ther; 2004 May; 18(3):211-7. PubMed ID: 15229389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
    Schleinitz MD; Olkin I; Heidenreich PA
    Am Heart J; 2004 Dec; 148(6):990-7. PubMed ID: 15632883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
    Ge J; Han Y; Jiang H; Sun B; Chen J; Zhang S; Du Z;
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):162-6. PubMed ID: 16044027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
    Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
    Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
    Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
    J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cilostazol on long-term clinical outcomes after coronary stenting].
    Han YL; Wang SL; Li Y; Jing QM; Ma YY; Deng J; Yang GT; Yu HB; Ge JB
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):814-7. PubMed ID: 16316558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
    J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative inhibitory effects of cilostazol and ticlopidine on subacute stent thrombosis and platelet function in acute myocardial infarction patients with percutaneous coronary intervention.
    Kawata M; Kuramoto E; Kataoka T; Saito A; Adachi K; Matsuura A; Sakamoto S
    Int Heart J; 2005 Jan; 46(1):13-22. PubMed ID: 15858933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
    Sekiguchi M; Hoshizaki H; Adachi H; Ohshima S; Taniguchi K; Kurabayashi M
    Circ J; 2004 Jul; 68(7):610-4. PubMed ID: 15226623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.
    Ahn Y; Jeong MH; Jeong JW; Kim KH; Ahn TH; Kang WC; Park CG; Kim JH; Chae IH; Nam CW; Hur SH; Bae JH; Kim KY; Oh SK
    Circ J; 2008 Jan; 72(1):35-9. PubMed ID: 18159096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.
    Sakurai R; Koo BK; Kaneda H; Bonneau HN; Nagai R
    Int J Cardiol; 2013 Sep; 167(5):2250-8. PubMed ID: 22727963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis.
    Jennings DL; Kalus JS
    J Clin Pharmacol; 2010 Apr; 50(4):415-21. PubMed ID: 20081227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trials.
    Hu FH; Yi X; Yang YJ; Qiao SB; Wu YJ; Yuan JS
    Exp Ther Med; 2013 Sep; 6(3):819-825. PubMed ID: 24137273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.